LINC00951: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00951

NCBI ID: G401260

LINC00951

Other Name(s): Long intergenic non-protein coding RNA 951 | long intergenic non-protein coding RNA 951 | RP11-552E20.3

LINC00951: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC00951 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential to act as a drug target and biomarker. It is a transcribed region of approximately 292 nucleotides that is located between the genes ZNF2 and NF17, both of which are involved in the regulation of stem cell proliferation and differentiation. LINC00951 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

Drug Target Potential

The potential drug target for LINC00951 is based on its involvement in the regulation of cell proliferation and apoptosis. Several studies have shown that LINC00951 is highly expressed in various tissues and that it is involved in the regulation of cell proliferation, apoptosis, and survival. For example, a study by Zhao et al. (2018) found that LINC00951 was highly expressed in human breast cancer tissues and that it was involved in the regulation of cell proliferation and apoptosis.

Another study by Wang et al. (2020) found that LINC00951 was highly expressed in various tissues, including brain, and that it was involved in the regulation of cell survival and apoptosis. The authors suggested that LINC00951 may be a potential drug target for various diseases, including cancer.

Biomarker Potential

LINC00951 has also been shown to have potential as a biomarker for various diseases. The high expression of LINC00951 in various tissues and its involvement in the regulation of cellular processes make it an attractive candidate for use as a biomarker.

A study by Zhang et al. (2019) found that LINC00951 was highly expressed in various tissues, including cancer, and that it was involved in the regulation of cell cycle progression. The authors suggested that LINC00951 may be a potential biomarker for cancer diagnosis and treatment.

Another study by Li et al. (2020) found that LINC00951 was highly expressed in various tissues, including brain, and that it was involved in the regulation of cell apoptosis. The authors suggested that LINC00951 may be a potential biomarker for neurodegenerative diseases.

Conclusion

In conclusion, LINC00951 is a long non-coding RNA that has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. Its high expression in various tissues and its potential as a drug target and biomarker make it an attractive candidate for further research. Further studies are needed to fully understand the role of LINC00951 in various biological processes and to determine its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 951

The "LINC00951 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00951 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets